MetLife Investment Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

MetLife Investment Management’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,238	Closed	-$139K	–	2784
2021 Q4	$139K	Hold	9,238	–	–	﹤0.01%	2280
2021 Q3	$242K	Hold	9,238	–	–	﹤0.01%	1969
2021 Q2	$462K	Hold	9,238	–	–	﹤0.01%	1616
2021 Q1	$425K	Hold	9,238	–	–	﹤0.01%	1625
2020 Q4	$396K	Hold	9,238	–	–	﹤0.01%	1595
2020 Q3	$377K	Hold	9,238	–	–	﹤0.01%	1519
2020 Q2	$506K	Buy	9,238 +848	+10%	+$48.5K	0.01%	1373
2020 Q1	$439K	Hold	8,390	–	–	0.01%	1286
2019 Q4	$408K	Hold	8,390	–	–	﹤0.01%	1570
2019 Q3	$461K	Sell	8,390 -1,724	-17%	-$98.7K	0.01%	1459
2019 Q2	$505K	Buy	10,114 +1,944	+24%	+$96.7K	0.01%	1475
2019 Q1	$461K	Hold	8,170	–	–	0.01%	1503
2018 Q4	$521K	Hold	8,170	–	–	0.01%	1343
2018 Q3	$663K	Hold	8,170	–	–	0.01%	1356
2018 Q2	$521K	Buy	8,170 +3,208	+65%	+$157K	0.01%	1389
2018 Q1	$193K	Hold	4,962	–	–	﹤0.01%	1912
2017 Q4	$139K	Buy	+4,962	New	+$145K	﹤0.01%	2112

Other funds holding TRHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MetLife Investment Management's TRHC Position: Q1 2022 in Review

MetLife Investment Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2022, closing a stake of 9,238 shares — an estimated $139K sold.

MetLife Investment Management first reported a position in TRHC in Q4 2017 and held it in 17 quarters. The position peaked at $663K in Q3 2018. 139 funds tracked by Wall St. Rank hold TRHC as of Q1 2022.

MetLife Investment Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 9,238 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2022, an estimated $139K.
MetLife Investment Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
MetLife Investment Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $663K in Q3 2018.
139 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.